Esomeprazole Magnesium For Suspension
Product Images NDC 69097-507

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 69097-507). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
A line graph depicting the percent of subjects maintained over a 6-month period for different doses of Esomeprazole magnesium (40 mg, 20 mg, 10 mg) compared to placebo. The x-axis represents months, and the y-axis represents percent maintained. Different line styles distinguish the dosage groups and placebo.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
A line graph showing the percentage of esomeprazole magnesium maintained over a 6-month period for different dosages (40 mg, 20 mg, 10 mg) and placebo. The x-axis represents months from 0 to 6, and the y-axis represents percent maintained from 0 to 100. Higher doses show greater maintenance over time compared to placebo.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
A line graph showing percent of patients symptom-free over 28 diary days, comparing esomeprazole magnesium 40 mg, esomeprazole magnesium 20 mg, and placebo. The y-axis represents percent of patients symptom-free from 0 to 100%, and the x-axis represents diary days from 0 to 28. Lines for the two dosage groups show higher symptom-free percentages than placebo throughout the study period.*
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
A line graph showing the percent of patients symptom-free over a 28-day diary period for Esomeprazole magnesium 40 mg, 20 mg, and placebo groups. The y-axis represents percent symptom-free patients, and the x-axis represents diary days. The 40 mg group shows the highest symptom-free percentage over time, followed by 20 mg and placebo.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of Esomeprazole magnesium showing the molecular framework including two magnesium ions and two water molecules, consistent with the drug's active ingredient in the oral suspension form by Cipla USA Inc.*
FDA Label Image

Unit Dose Package 2.5mg (Unit Dose 2 5mg)

Unit Dose Package 2.5mg (Unit Dose 2 5mg)
Packaging label for Esomeprazole Magnesium delayed-release oral suspension by Cipla USA Inc. The label shows two strength options: 2.5 mg per 1 packet and 25 mg per 1 packet. The product is in single-dose packets, with each carton containing 30 child-resistant packets. The label emphasizes pharmacist dispensing instructions and includes the NDC codes 69097-507-31 and 69097-507-01.*
FDA Label Image

Unit Dose Package 5 mg (Unit Dose 5mg)

Unit Dose Package 5 mg (Unit Dose 5mg)
Packaging label for Esomeprazole Magnesium 5 mg delayed-release oral suspension by Cipla USA Inc. The label shows a carton with text indicating it contains 30 child-resistant packets. The label includes dosage form, strength, ingredients, storage instructions, NDC code 69097-508-31, and a barcode. The design also notes space for pharmacy label application and batch overprinting area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.